Publications

Recent publications

  • Increased White Matter Aerobic Glycolysis in Multiple Sclerosis
    Increased White Matter Aerobic Glycolysis in Multiple SclerosisBrier, M. R., Judge, B., Ying, C., Salter, A., An, H., Patel, A., Wang, Q., Wang, Y., Cross, A. H., Naismith, R. T., Benzinger, T. L. S. & Goyal, M. S., Apr 2025, In: Annals of neurology. 97, 4, p. 766-778 13 p.Research output: Contribution to journal › Article › peer-review
  • Bile acid metabolites predict multiple sclerosis progression and supplementation is safe in progressive disease
    Bile acid metabolites predict multiple sclerosis progression and supplementation is safe in progressive diseaseLadakis, D. C., Harrison, K. L., Smith, M. D., Solem, K., Gadani, S., Jank, L., Hwang, S., Farhadi, F., Dewey, B. E., Fitzgerald, K. C., Sotirchos, E. S., Saidha, S., Calabresi, P. A. & Bhargava, P., Mar 14 2025, In: Med. 6, 3, 100522.Research output: Contribution to journal › Article › peer-review
  • Real world experience with cladribine tablets for multiple sclerosis at four academic multiple sclerosis centers
    Real world experience with cladribine tablets for multiple sclerosis at four academic multiple sclerosis centersConway, D. S., Nicholas, J. A., Thompson, N. R., Mowry, E. M. & Naismith, R. T., Feb 2025, In: Multiple Sclerosis and Related Disorders. 94, 106272.Research output: Contribution to journal › Article › peer-review
  • Cerebrospinal fluid biomarkers as predictors of multiple sclerosis severity
    Cerebrospinal fluid biomarkers as predictors of multiple sclerosis severityTolentino, M., Pace, F., Perantie, D. C., Mikesell, R., Huecker, J., Chahin, S., Ghezzi, L., Piccio, L. & Cross, A. H., Feb 2025, In: Multiple Sclerosis and Related Disorders. 94, 106268.Research output: Contribution to journal › Article › peer-review
  • A single-cell compendium of human cerebrospinal fluid identifies disease-associated immune cell populations
    A single-cell compendium of human cerebrospinal fluid identifies disease-associated immune cell populationsCantoni, C., Smirnov, R. A., Firulyova, M., Andhey, P. S., Bradstreet, T. R., Esaulova, E., Terekhova, M., Schwarzkopf, E. A., Abdalla, N. M., Kleverov, M., Sabatino, J. J., Liu, K., Schwab, N., Meyer Zu Hörste, G., Cross, A. H., Artyomov, M. N., Edelson, B. T. & Wu, G. F., Jan 2 2025, In: Journal of Clinical Investigation. 135, 1, e177793.Research output: Contribution to journal › Article › peer-review
  • A digital version of the nine-hole peg test: Speed may be a more reliable measure of upper-limb disability than completion time in patients with multiple sclerosis
    A digital version of the nine-hole peg test: Speed may be a more reliable measure of upper-limb disability than completion time in patients with multiple sclerosisJiang, X., McGinley, M., Johnston, J., Alberts, J., Bermel, R., Ontaneda, D., Naismith, R. T., Hyde, R., Levitt, N., van Beek, J., Sun, Z., Campbell, N. & Barro, C., Jan 2025, In: Multiple Sclerosis Journal. 31, 1, p. 81-92 12 p.Research output: Contribution to journal › Article › peer-review
  • Subcutaneous ocrelizumab in multiple sclerosis: Results of the Phase 1b OCARINA I study
    Subcutaneous ocrelizumab in multiple sclerosis: Results of the Phase 1b OCARINA I studyNewsome, S. D., Goldstick, L., Robertson, D. S., Bowen, J. D., Naismith, R. T., Townsend, B., Figueiredo, C., Kletzl, H., Giraudon, M., Bortolami, O., Zecevic, D., Giacobino, C., Clinch, S., Shen, Y. A., Deol-Bhullar, G. & Bermel, R. A., Dec 2024, In: Annals of Clinical and Translational Neurology. 11, 12, p. 3215-3226 12 p.Research output: Contribution to journal › Article › peer-review
  • Cis-regulatory evolution of the recently expanded Ly49 gene family
    Cis-regulatory evolution of the recently expanded Ly49 gene familyFan, C., Xing, X., Murphy, S. J. H., Poursine-Laurent, J., Schmidt, H., Parikh, B. A., Yoon, J., Choudhary, M. N. K., Saligrama, N., Piersma, S. J., Yokoyama, W. M. & Wang, T., Dec 2024, In: Nature communications. 15, 1, 4839.Research output: Contribution to journal › Article › peer-review
  • A 2-stage model of heterogenous treatment effects for brain atrophy in multiple sclerosis utilizing the MS PATHS research network
    A 2-stage model of heterogenous treatment effects for brain atrophy in multiple sclerosis utilizing the MS PATHS research networkHersh, C. M., Sun, Z., Conway, D. S., Sotirchos, E. S., Fitzgerald, K. C., Hua, L. H., Ziemssen, T., Naismith, R. T., Pellegrini, F., Grossman, C. & Campbell, N., Nov 2024, In: Multiple Sclerosis and Related Disorders. 91, 105847.Research output: Contribution to journal › Article › peer-review
  • Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials
    Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trialsMontalban, X., Vermersch, P., Arnold, D. L., Bar-Or, A., Cree, B. A. C., Cross, A. H., Kubala Havrdova, E., Kappos, L., Stuve, O., Wiendl, H., Wolinsky, J. S., Dahlke, F., Le Bolay, C., Shen Loo, L., Gopalakrishnan, S., Hyvert, Y., Javor, A., Guehring, H., Tenenbaum, N. & Tomic, D., Nov 2024, In: The Lancet Neurology. 23, 11, p. 1119-1132 14 p.Research output: Contribution to journal › Article › peer-review
Complete research profile